Journey Medical Corporati... (DERM)
NASDAQ: DERM
· Real-Time Price · USD
6.39
-0.12 (-1.84%)
At close: Jun 23, 2025, 3:48 PM
-1.84% (1D)
| Bid | 6.35 |
| Market Cap | 148.87M |
| Revenue (ttm) | 56.24M |
| Net Income (ttm) | -8.3M |
| EPS (ttm) | -0.37 |
| PE Ratio (ttm) | -17.27 |
| Forward PE | 7.22 |
| Analyst | Buy |
| Ask | 6.4 |
| Volume | 121,830 |
| Avg. Volume (20D) | 104,062 |
| Open | 6.45 |
| Previous Close | 6.51 |
| Day's Range | 6.24 - 6.54 |
| 52-Week Range | 3.54 - 8.25 |
| Beta | 0.88 |
About DERM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DERM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DERM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Journey Medical Corporation is scheduled to release its earnings on Aug 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+18.93%
Journey Medical shares are trading higher after th...
Unlock content with
Pro Subscription
10 months ago
+14.22%
Journey Medical shares are trading higher after the company reported better-than-expected Q2 revenue results.
1 month ago · seekingalpha.com
Journey Medical Corporation (DERM) Q1 2025 Earnings Call TranscriptJourney Medical Corporation (NASDAQ:DERM ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants Jaclyn Jaffe - Senior Director, Corporate Operations Claude Maraoui - Co-Founde...
2 months ago · seekingalpha.com
Journey Medical Corporation (DERM) Q4 2024 Earnings Call TranscriptJourney Medical Corporation (NASDAQ:DERM ) Q4 2024 Results Conference Call March 26, 2025 4:30 PM ET Company Participants Jaclyn Jaffe - Senior Director, Corporate Operations Claude Maraoui - Co-Found...
